Post-IPO Equity Therapeutics Companies

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.

Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

Dermata Therapeutics is a biotechnology firm that focuses on advancements in the treatment of serious diseases treated by dermatologists.

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Defence Therapeutics is a scientific pioneer on a journey to uncover enhanced treatment solutions for future generations.

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.